These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6300061

  • 1. The influence of Na+ on the alpha 2-adrenergic receptor system of human platelets. A method for removal of extraplatelet Na+. Effect of Na+ removal on aggregation, secretion, and cAMP accumulation.
    Connolly TM, Limbird LE.
    J Biol Chem; 1983 Mar 25; 258(6):3907-12. PubMed ID: 6300061
    [No Abstract] [Full Text] [Related]

  • 2. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM, Limbird LE.
    Proc Natl Acad Sci U S A; 1983 Sep 25; 80(17):5320-4. PubMed ID: 6577431
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
    Mooney JJ, Horne WC, Handin RI, Schildkraut JJ, Alexander RW.
    Mol Pharmacol; 1982 May 25; 21(3):600-8. PubMed ID: 6287197
    [No Abstract] [Full Text] [Related]

  • 9. Relationships between membrane cholesterol, alpha-adrenergic receptors, and platelet function.
    Insel PA, Nirenberg P, Turnbull J, Shattil SJ.
    Biochemistry; 1978 Nov 28; 17(24):5269-74. PubMed ID: 215196
    [No Abstract] [Full Text] [Related]

  • 10. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F, Cazenave JP, Beretz A, Sutter-Bay A, Kretz JG, Kieny R.
    Agents Actions; 1986 Aug 28; 18(5-6):586-95. PubMed ID: 3020942
    [Abstract] [Full Text] [Related]

  • 11. Interaction of verapamil with human platelet alpha-adrenergic receptors.
    Barnathan ES, Addonizio VP, Shattil SJ.
    Am J Physiol; 1982 Jan 28; 242(1):H19-23. PubMed ID: 6277203
    [Abstract] [Full Text] [Related]

  • 12. Agonist regulation of the human platelet alpha-adrenergic receptor.
    Cooper B, Handin RI, Young LH, Alexander RW.
    Nature; 1978 Aug 17; 274(5672):703-6. PubMed ID: 209342
    [No Abstract] [Full Text] [Related]

  • 13. Hormonal inhibition of adenylate cyclase. alpha 2 Adrenergic receptors promote release of [3H]guanylylimidodiphosphate from platelet membranes.
    Michel T, Lefkowitz RJ.
    J Biol Chem; 1982 Nov 25; 257(22):13557-63. PubMed ID: 6292195
    [No Abstract] [Full Text] [Related]

  • 14. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M, Welzel D, Wolf H, Honey A, Kakkar VV.
    Arzneimittelforschung; 1987 Jun 25; 37(6):669-74. PubMed ID: 2822055
    [Abstract] [Full Text] [Related]

  • 15. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F, Beretz A, Stierlé A, Hanau D, Kubina M, Cazenave JP.
    Am J Physiol; 1988 Dec 25; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [Abstract] [Full Text] [Related]

  • 16. Solubilization of human platelet alpha-adrenergic receptors: evidence for agonist-promoted receptor-effector association.
    Limbird LE, MacMillan ST, Smith SK.
    Adv Cyclic Nucleotide Res; 1981 Dec 25; 14():189-98. PubMed ID: 6116384
    [No Abstract] [Full Text] [Related]

  • 17. Influence of phospholipase A2 on human blood platelet alpha adrenergic receptor function.
    Rao GH, White JG.
    Thromb Res; 1989 Mar 01; 53(5):427-34. PubMed ID: 2544037
    [Abstract] [Full Text] [Related]

  • 18. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
    Karliner JS, Motulsky HJ, Insel PA.
    Mol Pharmacol; 1982 Jan 01; 21(1):36-43. PubMed ID: 6127620
    [No Abstract] [Full Text] [Related]

  • 19. Platelet alpha-2 adrenoceptor-mediated primary aggregation and adenylate cyclase inhibition in depressed patients.
    Karege F, Bovier P, Hilleret H, Gaillard JM.
    Lancet; 1993 Apr 17; 341(8851):1029. PubMed ID: 8096917
    [No Abstract] [Full Text] [Related]

  • 20. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr 17; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.